Company Chordate Medical Holding AB
Equities
CMH
SE0009495559
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0526 SEK | -17.55% | -18.07% | -67.21% |
May. 07 | Chordate Medical Receives Patent Approval in the US | CI |
Mar. 22 | Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 3
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Neuromodulation Treatment Technology
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +799.66% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
50.6
%
| 0 | 44.9 % | 0 | 50.6 % | +913.93% |
European Union
49.4
%
| 0 | 55.1 % | 0 | 49.4 % | +706.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 14-10-31 | |
Director of Finance/CFO | 56 | 17-10-01 | |
Jan Hermansson
CTO | Chief Tech/Sci/R&D Officer | 68 | 11-12-31 |
Jan Lindberg
CTO | Chief Tech/Sci/R&D Officer | 68 | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 14-05-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 61 | 17-03-31 |
Chief Executive Officer | 63 | 14-10-31 | |
Director/Board Member | 62 | 23-04-30 | |
Chairman | 50 | 14-10-31 | |
Director/Board Member | 45 | 21-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 306,024,605 | 113,096,842 ( 36.96 %) | 0 | 36.96 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-67.21% | 2.4M | |
+12.85% | 229B | |
+13.88% | 195B | |
+18.39% | 142B | |
+28.78% | 109B | |
+1.67% | 64.85B | |
+18.24% | 54.33B | |
+7.04% | 52.09B | |
+10.83% | 45.15B | |
+5.94% | 37.39B |
- Stock Market
- Equities
- CMH Stock
- Company Chordate Medical Holding AB